Inozyme Pharma Inc. (INZY)
NASDAQ: INZY
· Real-Time Price · USD
4.00
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM
Inozyme Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -106.72M | -102.02M | -96.49M | -88.56M | -77.11M | -71.17M | -68.17M | -67.9M | -67.58M | -67.06M | -67.27M | -65.18M | -62.46M | -56.62M | -48.99M | -62.8M | -59.74M |
Depreciation & Amortization | 51K | 742K | 871K | 884K | 905K | 930K | 822K | 803K | 773K | 744K | 728K | 706K | 694K | 674K | 615K | 491K | 350K |
Stock-Based Compensation | 8.11M | 7.95M | 7.65M | 7.19M | 6.64M | 7.04M | 7.25M | 7.43M | 8.01M | 7.67M | 7.81M | 7.71M | 7.34M | 7.16M | 6.42M | 5.45M | 3.76M |
Other Working Capital | 5.69M | 3.35M | 1.62M | -708K | -2.65M | -1.7M | -4.17M | -1.14M | -488K | 1.86M | 1.74M | 1.78M | 3.56M | 760K | -2.06M | -4.4M | -4.74M |
Other Non-Cash Items | -393K | -1.06M | 301K | 973K | 1.21M | 1.32M | -352K | -1.02M | -1.7M | -1.13M | -633K | -179K | 315K | 378K | 416K | 18.3M | 18.17M |
Deferred Income Tax | n/a | n/a | -3.13M | -4.61M | -5.72M | -5.72M | -2.59M | -1.1M | n/a | n/a | 24K | 54K | 112K | 170K | 146K | 116K | 58K |
Change in Working Capital | 6.05M | 4.71M | 1.82M | 805K | -2.3M | -3.08M | -3.55M | -434K | -873K | 2.01M | 2.54M | 2.3M | 4.06M | 85K | -4.19M | -5.04M | -4.68M |
Operating Cash Flow | -96.52M | -91.91M | -91.21M | -85.55M | -77.44M | -70.67M | -66.59M | -62.23M | -61.37M | -57.76M | -56.8M | -54.59M | -49.94M | -48.15M | -45.58M | -43.48M | -42.09M |
Capital Expenditures | -30K | -62K | -150K | -144K | -155K | -298K | -239K | -379K | -568K | -410K | -404K | -336K | -326K | -397K | -172K | -678K | -555K |
Cash Acquisitions | n/a | n/a | 6.37K | 50.97K | 67.29K | 53.35K | 46.98K | 10.48K | 16.89K | 30.84K | 30.84K | 22.73K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -123.66M | -155.05M | -184.36M | -261.24M | -272.6M | -269.33M | -237.45M | -177.22M | -167.63M | -151.99M | -142.98M | -141.58M | -113.84M | -121.97M | -157.43M | -221.05M | -203.06M |
Sales Maturities Of Investments | 213.98M | 222.11M | 229.6M | 238.51M | 215.73M | 215.98M | 193.73M | 170M | 154M | 147M | 144.25M | 164.1M | 178.95M | 165.16M | 170.95M | 122.35M | 90.42M |
Other Investing Acitivies | 17.82M | 28.24M | 28.24M | 28.19M | 10.36M | -53.35K | -46.98K | -10.48K | -16.89K | 22.55M | 32.08M | 45.22M | 65.11M | 43.19M | 13.52M | -98.7M | -112.64M |
Investing Cash Flow | 90.29M | 67M | 45.09M | -22.88M | -57.02M | -53.65M | -43.96M | -7.6M | -14.2M | -5.4M | 866K | 22.18M | 64.78M | 42.8M | 13.35M | -99.38M | -113.2M |
Debt Repayment | n/a | n/a | 12.5M | 12.5M | 20M | 40M | 27.5M | 31.55M | 24.05M | 4.05M | 4.05M | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | 148K | 148K | 148K | 148K | 96K | 96K | 96K | 96K | n/a | n/a | n/a | n/a | n/a | -986K | -986K | -986K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 718K | 877K | 716K | 786K | 16.47M | 16.41M | 16.39M | 16.4M | 68.59M | 68.74M | 68.75M | 68.82M | 600K | 609K | 598K | 119.22M | 117.4M |
Financial Cash Flow | 11.47M | 11.4M | 23.66M | 82.85M | 106.03M | 125.97M | 113.45M | 47.95M | 92.64M | 72.79M | 72.8M | 68.82M | 600K | 609K | -388K | 118.24M | 150.06M |
Net Cash Flow | 5.54M | -13.2M | -22.01M | -25.61M | -28.45M | 1.63M | 2.81M | -21.82M | 17.08M | 9.6M | 16.82M | 36.38M | 15.46M | -4.72M | -32.63M | -24.63M | -5.23M |
Free Cash Flow | -96.55M | -91.97M | -91.36M | -85.69M | -77.59M | -70.97M | -66.83M | -62.61M | -61.94M | -58.17M | -57.21M | -54.93M | -50.26M | -48.55M | -45.76M | -44.16M | -42.64M |